Dr Reddys Laboratories Ltd's share price has fallen by -0.08%, presenting both challenges and opportunities for investors. As of now, it's trading at ₹1,279.50, and market participants are assessing the implications. The stock has a PE ratio of 18.5200, an ROE of 16.0277% and a debt to equity ratio of 0.1625.







